1632 Federal Register / Vol. 73, No.
6 / Wednesday, January 9, 2008 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Virtual Meeting).
Contact Person: Mark Swieter, PhD, Chief,
Training and Special Projects Review Branch,
Office of Extramural Affairs, National
Institute on Drug Abuse, NIH, DHHS, 6101
Executive Boulevard, Suite 200, Bethesda,
MD 20892–8401, (301) 435–1389,
ms80x@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, NIDA F
New Investigator R01 Member Conflicts.
Date: February 15, 2008.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Gerald L. McLaughlin,
PhD, Scientific Review Administrator, Office
of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Blvd., Bethesda, MD
20892–8401, 301–402–6626,
gm145a@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, NIDA–
F New Investigator R01s Sep.
Date: February 15, 2008.
Time: 12 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Meenaxi Hiremath, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6101 Executive Blvd., Suite 220, MSC
8401, Bethesda, MD 20892, 301–402–7964,
mh392g@nih.gov.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Health
Services Research Subcommittee.
Date: March 4–5, 2008.
Time: 8:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Jurys Washington Hotel, 1500 New
Hampshire Ave. NW., Washington, DC
20036.
Contact Person: Meenaxi Hiremath, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6101 Executive Blvd., Suite 220, MSC
8401, Bethesda, MD 20892, 301–402–7964,
mh392g@nih.gov.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Treatment
Research Subcommittee.
Date: March 4–5, 2008.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
pwalker on PROD1PC71 with NOTICES
applications.
Place: Jurys Washington Hotel, 1500 New
Hampshire Avenue, NW., Washington, DC
20036.
Contact Person: Kesinee Nimit, MD.,
Health Scientist Administrator, Office of
VerDate Aug<31>2005 17:53 Jan 08, 2008 Jkt 214001
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Boulevard, Bethesda,
MD 20892–8401, (301) 435–1432.
Name of Committee: National Institute on
Drug Abuse Initial Review Group, Training
and Career Development Subcommittee.
Date: March 11–13, 2008.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Ave., NW., Washington, DC 20037.
Contact Person: Eliane Lazar-Wesley, PhD,
Health Scientist Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6101 Executive
Boulevard, Room 220, MSC 8401, Bethesda,
MD 20892–8401, 301–451–4530,
el6r@nih.gov.
Name of Committee: National Institute on
Drug Abuse Initial Review Group,
Medication Development Research
Subcommittee.
Date: March 13, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Omni Shoreham Hotel, 2500 Calvert
Street, NW., Washington, DC 20008.
Contact Person: Gerald L. McLaughlin,
PhD, Health Scientist Administrator, Office
of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Boulevard, Bethesda,
MD 20892–8401, 301–402–6626,
gm145a@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: January 3, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–43 Filed 1–8–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\09JAN1.SGM
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Synthesis and Distribution of Drugs of Abuse
and Related Compounds.
Date: January 23, 2008.
Time: 9 a.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, Drug
Abuse Screening, Assessment, Patient-
Treatment Matching Technologies for Use in
Primary Care.
Date: January 24, 2008.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Kristen V. Huntley, PhD.,
Scientific Review Administrator, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC
8401, 6101 Executive Boulevard, Bethesda,
MD 20892–8401, 301–435–1433,
huntleyk@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Development of Nanoscience-based Probes,
Delivery Systems, and Therapies for
Substance Use Disorders.
Date: January 30, 2008.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: January 3, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–44 Filed 1–8–08; 8:45 am]
BILLING CODE 4140–01–M
09JAN1